Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The U.S. Food and Drug Administration approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.

  • The World Health Organization (WHO) is to launch a pilot project this year to evaluate inexpensive copies of costly drugs for biotechnology cancer to make these drugs more accessible in the poorest countries.

  • The US House of Representatives, controlled by the Republicans, passed a new version of the American Health Care Act to repeal and replace Obamacare, by a vote of 217 to 213. The Republican leaders of the house have blurred to gain sufficient support for the vote after adding a series of changes since an earlier version was taken from a vote in Parliament at the last minute of March.

  • Takeda Pharmaceutical Company Limited announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under Accelerated Approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. ALUNBRIG, which previously received Breakthrough Therapy Designation from the FDA, is a once-daily oral therapy that may be taken with or without food.

Subscribe to Pharma News